PubMed COVID-19 Clinical Care
47921 - 47930 of 57555 results found
Descriptive assessment of COVID-19 responses and lessons learnt in Cambodia, January 2020 to June 2022
Description
As a member state of the International Health Regulations 2005, Cambodia is continuously strengthening its capacity to respond to health emergencies and prevent the international spread of diseases. Despite this, Cambodia's capacity to prevent
Commentary on "Convalescent Plasma Therapy in Late-State, Severe COVID-19 Infection"
Description
No abstract
An analysis of suicide rates in Kerman province, the largest province in Iran, before and after COVID-19: (2017-2020)
Description
This study aimed to investigate the suicide incidence rate in Kerman before and after the pandemic and the characteristics of suicides. During four years, 642 suicide occurred in Kerman province. The suicide rate of suicide has increased in 2020
Waning effectiveness against COVID-19-related hospitalisation, severe complications, and mortality with two to three doses of CoronaVac and BNT162b2: a case-control study
Description
CONCLUSIONS: Significant risk reduction against COVID-19-related hospitalisation and mortality after CoronaVac or BNT162b2 vaccination was observed for >240 and >120 days after second and third dose compared to unvaccinated, despite significant
OPTN/SRTR 2021 Annual Data Report: Lung
Description
The number of lung transplants has continued to decline since 2020, a period that coincides with the onset of the COVID-19 pandemic. Lung allocation policy continues to undergo considerable change in preparation for adoption of the Composite
Laboratory methods: A concise review and update for COVID-19 diagnosis
Description
Since late December 2019, coronavirus disease 2019 (COVID-19) outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been rapidly spread across the globe. The early, safe, sensitive, and accurate diagnosis of viral
A review on Artificial Intelligence Approaches and Rational approaches in Drug Discovery
Description
Artificial intelligence (AI) speeds up the drug development process and reduces its time, as well as the cost which is of enormous importance in outbreaks such as COVID-19. It uses a set of machine learning algorithms that collects the available data
Cui bono? Large-scale evidence on the impact of COVID-19 policy measures on listed firms
Description
By using a large international firm-level data set this paper aims to make a contribution in better understanding how COVID-19 related stringency and economic support measures actually affected the corporate sector. Our most important findings can be
Sales of antibiotics without a prescription in pharmacies, 2017 and 2021, China
Description
CONCLUSION: Although laws became stricter between 2017 and 2021, antibiotic sales without a prescription were still common in pharmacies across China. Existing regulations need to be more strictly enforced, and pharmacy staff and the public should be
